Karyopharm Therapeutics Inc. Gains 69.65%
Mon 02 Mar 20 at 05:30 PM
Karyopharm Therapeutics Inc. (KPTI:NASDAQ) rocketted at $27.72, a gain of 69.6%. The stock appeared on our News Catalysts scanner on Mon 02 Mar 20 at 05:09 PM in the 'BIOTECH' category. From Fri 07 Feb 20, the stock recorded 35.71% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Karyopharm Therapeutics Inc. (KPTI:NASDAQ)
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class drugs directed against nuclear transport and related targets to treat cancer and other diseases.
Top 10 Gainers:
- Heat Biologics, Inc. (HTBX:NASDAQ), 142.42%
- Novan, Inc. (NOVN:NASDAQ), 112.51%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 100%
- BioPharmX Corporation (BPMX:NYSEMKT), 78.38%
- Karyopharm Therapeutics Inc. (KPTI:NASDAQ), 69.65%
- Daxor Corporation (DXR:NYSEMKT), 65.7%
- Forty Seven, Inc. (FTSV:NASDAQ), 61.91%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 55.83%
- NuCana plc (NCNA:NASDAQ), 45.74%
- InflaRx N.V. (IFRX:NASDAQ), 43.4%